Novavax (NVAX) Reports In-Line Q3 EPS
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $10.11 +1.10%
Financial Fact:
Research and development: 52.98M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Financial Fact:
Research and development: 52.98M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q3 EPS of ($0.12), in-line with the analyst estimate of ($0.12). Revenue for the quarter came in at $7.7 million versus the consensus estimate of $9.4 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- UBS Reiterates Neutral Rating on Intuit (INTU), Says Investor Day Not 'Sentiment-Changing'
- Barclays says AI trade is maturing, favors greater diversification
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
